16 min

Repurposing rheumatology drugs for COVID-19: TNF inhibitors Medicine Matters rheumatology

    • Medicine

Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.

  • Springer Healthcare, part of the Springer Nature group

Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.

16 min

  • Springer Healthcare, part of the Springer Nature group